Abacavir-induced liver toxicity

Detalhes bibliográficos
Autor(a) principal: Pezzani,Maria Diletta
Data de Publicação: 2016
Outros Autores: Resnati,Chiara, Di Cristo,Valentina, Riva,Agostino, Gervasoni,Cristina
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502
Resumo: Abstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine.
id BSID-1_64937d51fb7975622950730cd52109b3
oai_identifier_str oai:scielo:S1413-86702016000500502
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Abacavir-induced liver toxicityHIVAbacavirLiver toxicityAbstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine.Brazilian Society of Infectious Diseases2016-10-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502Brazilian Journal of Infectious Diseases v.20 n.5 2016reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2016.03.002info:eu-repo/semantics/openAccessPezzani,Maria DilettaResnati,ChiaraDi Cristo,ValentinaRiva,AgostinoGervasoni,Cristinaeng2016-10-26T00:00:00Zoai:scielo:S1413-86702016000500502Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2016-10-26T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Abacavir-induced liver toxicity
title Abacavir-induced liver toxicity
spellingShingle Abacavir-induced liver toxicity
Pezzani,Maria Diletta
HIV
Abacavir
Liver toxicity
title_short Abacavir-induced liver toxicity
title_full Abacavir-induced liver toxicity
title_fullStr Abacavir-induced liver toxicity
title_full_unstemmed Abacavir-induced liver toxicity
title_sort Abacavir-induced liver toxicity
author Pezzani,Maria Diletta
author_facet Pezzani,Maria Diletta
Resnati,Chiara
Di Cristo,Valentina
Riva,Agostino
Gervasoni,Cristina
author_role author
author2 Resnati,Chiara
Di Cristo,Valentina
Riva,Agostino
Gervasoni,Cristina
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Pezzani,Maria Diletta
Resnati,Chiara
Di Cristo,Valentina
Riva,Agostino
Gervasoni,Cristina
dc.subject.por.fl_str_mv HIV
Abacavir
Liver toxicity
topic HIV
Abacavir
Liver toxicity
description Abstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine.
publishDate 2016
dc.date.none.fl_str_mv 2016-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2016.03.002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.20 n.5 2016
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209243792146432